StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance NASDAQ:SRNE opened at $0.04 on Wednesday. Sorrento Therapeutics has a 52 week low of $0.16 and a 52 week […]
Sorrento Therapeutics (NASDAQ:SRNE) Now Covered by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Sorrento Therapeutics stock opened at $0.15 on Friday. The company has a debt-to-equity ratio of 0.14, a quick […]
Analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report released on Saturday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Down 20.3 % Shares of NASDAQ:SRNE opened at $0.31 on Friday. The business’s 50 day moving average is $0.31 and its […]
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Sorrento Therapeutics stock opened at $0.31 on Friday. Sorrento Therapeutics has a twelve month low of $0.16 and […]